ClinicalTrials.govpublic full text
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
diabetic macular edema (dme), dme, ksi-501, tabirafusp tedromer, aflibercept, antibody biopolymer conjugate, anti-vegf, anti-il-6, kodiak sciences, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 898866
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.